Susanne Roehrig

1PUBLICATIONS
4CO-AUTHORS
Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 05, 2023
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.

Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez

Pageof 1

Frequent Collaborators

1 joint publications

Dieter Lang

1 joint publications

Daniel Meibom

1 joint publications

Markus Follmann

1 joint publications

Alexander Hillisch